| Semaphorins in health and disease D Fard, L Tamagnone Cytokine & growth factor reviews 57, 55-63, 2021 | 62 | 2021 |
| Reverse signaling by semaphorin 4C elicits SMAD1/5-and ID1/3-dependent invasive reprogramming in cancer cells S Gurrapu, G Franzolin, D Fard, M Accardo, E Medico, I Sarotto, A Sapino, ... Science signaling 12 (595), eaav2041, 2019 | 21 | 2019 |
| Taurine administration counteracts aging-associated impingement of skeletal muscle regeneration by reducing inflammation and oxidative stress A Barbiera, S Sorrentino, D Fard, E Lepore, G Sica, G Dobrowolny, ... Antioxidants 11 (5), 1016, 2022 | 12 | 2022 |
| L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab I Marrocco, S Giri, A Simoni-Nieves, N Gupta, A Rudnitsky, Y Haga, ... Cell Reports Medicine 4 (8), 2023 | 6 | 2023 |
| SEMA6C: a novel adhesion-independent FAK and YAP activator, required for cancer cell viability and growth D Fard, E Testa, V Panzeri, S Rizzolio, G Bianchetti, V Napolitano, ... Cellular and Molecular Life Sciences 80 (4), 111, 2023 | 4 | 2023 |
| Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer D Fard, E Giraudo, L Tamagnone Trends in Molecular Medicine, 2023 | 3 | 2023 |
| Semaphorins: Missing Signals in Age-dependent Alteration of Neuromuscular Junctions and Skeletal Muscle Regeneration D Fard, A Barbiera, G Dobrowolny, L Tamagnone, BM Scicchitano Aging and Disease 15 (2), 517, 2024 | 1 | 2024 |
| LENTIVIRAL MEDIATING GENETIC ENGINEERED OLFACTORY ENSHEATHING CELL RELEASING CNTF GENE AS A GENE THERAPY APPROACH FOR SPINAL CORD INJURY D FARD, MM FORGHANIFARD | | 2017 |
